Trial Profile
Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Difluprednate (Primary)
- Indications Postoperative inflammation
- Focus Therapeutic Use
- Sponsors Sirion Therapeutics
- 24 Dec 2014 New trial record